Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence — Stella

Home/Langerhans Cell Histiocytosis of Bone/

View on ClinicalTrials.gov

Recruiting

Back to Langerhans Cell Histiocytosis of Bone trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Shanghai Changzheng Hospital, Shanghai, Shanghai Municipality

Key details

Phase

Safety & dosing

Sponsor

Shanghai Changzheng Hospital

Collaborators

First Affiliated Hospital of Zhejiang University, Peking University Third Hospital

Enrollment target

~118 participants

Started

November 2023

Primary completion

September 2027

Age range

2 Years – 17 Years

Last updated February 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.